亚太疫苗市场至 2027 年 - 按技术划分的区域分析和预测（重组疫苗、结合疫苗、减毒活疫苗、灭活疫苗和亚单位疫苗以及类毒素疫苗）；疾病适应症（DTP（白喉破伤风类毒素和百日咳）、流感、肝炎、呼吸道合胞病毒（RSV）和其他疾病）；给药途径（口服、注射和其他给药途径）；患者类型（儿童患者和成人患者）和国家/地区
No. of Pages: 152 | Report Code: TIPRE00005749 | Category: Life Sciences
No. of Pages: 152 | Report Code: TIPRE00005749 | Category: Life Sciences
亚太地区人类疫苗市场预计将从 2018 年的 72.545 亿美元增至 2027 年的 126.314 亿美元。预计从 2019 年开始，该市场将以 6.4% 的复合年增长率增长-2027年。
市场的增长是由认知度上升等因素推动的亚太地区疫苗接种计划、活动和会议以及亚太地区疫苗产量的增长可能会在预测期内扩大疫苗市场。然而，亚太地区对免疫的不信任可能会影响预测期内疫苗市场的增长。
每个亚太地区每年有数千名儿童死亡，还有更多儿童因疫苗可预防的疾病而住院。这些疾病的治疗费用非常高。据全球疫苗免疫联盟称，亚太地区有五分之一的儿童无法获得基本疫苗。因此，在亚太地区，政府开展了许多提高认识计划，以提高人们的认识。亚太地区免疫合作伙伴 (IPAP) 于 2017 年 4 月在新加坡举办了第六届亚洲疫苗会议 (ASVAC 2017)。
国家亚太地区正在联手通过疫苗接种消除麻疹、白喉、风疹、百日咳等传染病。亚太地区正在举办多项疫苗接种计划、活动和会议，以提高人们的认识。例如，印度与世界卫生组织东南亚区域其他成员国一道发起了一项到 2020 年根除麻疹并控制风疹/先天性风疹综合征 (CRS) 的运动。家庭福利计划旨在为印度 4.1 亿儿童提供免疫接种。该活动的第一阶段于 2017 年 2 月在泰米尔纳德邦、卡纳塔克邦、果阿、拉克沙群岛和本地治里五个邦成功完成。超过 3.3 亿儿童接种了疫苗，覆盖目标年龄组的 97%。该活动在学校、社区中心和其他医疗机构开展。
日本预计将引领亚太地区市场由于主要市场参与者的存在、政府对疫苗研究的资助，以及该国在全国范围内拥有强大且不断发展的疫苗接种计划。各种疾病预防性疫苗接种的发展可能会推动该国疫苗接种市场的发展。因此，考虑到上述因素，该国市场的增长很可能在预测期内贡献亚太地区最大的份额。
亚太地区疫苗–市场细分
按技术
亚太疫苗 -市场细分
按疾病适应症
亚太疫苗 -市场细分
按
管理方式
亚太地区疫苗 –市场细分
按患者类型
按国家/地区
提及的公司
Strategic insights for Asia Pacific Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 7,254.5 Million |
| Market Size by 2027 | US$ 12,631.4 Million |
| Global CAGR (2019 - 2027) | 6.4% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific Vaccines Market
The Asia Pacific Vaccines Market is valued at US$ 7,254.5 Million in 2018, it is projected to reach US$ 12,631.4 Million by 2027.
As per our report Asia Pacific Vaccines Market, the market size is valued at US$ 7,254.5 Million in 2018, projecting it to reach US$ 12,631.4 Million by 2027. This translates to a CAGR of approximately 6.4% during the forecast period.
The Asia Pacific Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Vaccines Market report:
The Asia Pacific Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Vaccines Market
